Literature DB >> 22199015

Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).

Peter Damman1, Lars Wallentin, Keith A A Fox, Fons Windhausen, Alexander Hirsch, Tim Clayton, Stuart J Pocock, Bo Lagerqvist, Jan G P Tijssen, Robbert J de Winter.   

Abstract

BACKGROUND: The present study was designed to investigate the long-term prognostic impact of procedure-related and spontaneous myocardial infarction (MI) on cardiovascular mortality in patients with non-ST-elevation acute coronary syndrome. METHODS AND
RESULTS: Five-year follow-up after procedure-related or spontaneous MI was investigated in the individual patient pooled data set of the FRISC-II (Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Randomized Intervention Trial of Unstable Angina 3) non-ST-elevation acute coronary syndrome trials. The principal outcome was cardiovascular death up to 5 years of follow-up. Cumulative event rates were estimated by the Kaplan-Meier method; hazard ratios were calculated with time-dependent Cox proportional hazards models. Adjustments were made for the variables associated with long-term outcomes. Among the 5467 patients, 212 experienced a procedure-related MI within 6 months after enrollment. A spontaneous MI occurred in 236 patients within 6 months. The cumulative cardiovascular death rate was 5.2% in patients who had a procedure-related MI, comparable to that for patients without a procedure-related MI (hazard ratio 0.66; 95% confidence interval, 0.36-1.20, P=0.17). In patients who had a spontaneous MI within 6 months, the cumulative cardiovascular death rate was 22.2%, higher than for patients without a spontaneous MI (hazard ratio 4.52; 95% confidence interval, 3.37-6.06, P<0.001). These hazard ratios did not change materially after risk adjustments.
CONCLUSIONS: Five-year follow-up of patients with non-ST-elevation acute coronary syndrome from the 3 trials showed no association between a procedure-related MI and long-term cardiovascular mortality. In contrast, there was a substantial increase in long-term mortality after a spontaneous MI.

Entities:  

Mesh:

Year:  2011        PMID: 22199015     DOI: 10.1161/CIRCULATIONAHA.111.061663

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  Periprocedural myocardial enzyme elevation: prognostic implications for current practice.

Authors:  Sanjum S Sethi; Avtar Singh; Michael E Farkouh
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 2.  The evolving role of cardiac troponin in the evaluation of cardiac disorders.

Authors:  Paul Anaya; David J Moliterno
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

Review 3.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

Review 4.  Prognostic relevance of PCI-related myocardial infarction.

Authors:  Pier Woudstra; Maik J Grundeken; Tim P van de Hoef; Lars Wallentin; Keith A Fox; Robbert J de Winter; Peter Damman
Journal:  Nat Rev Cardiol       Date:  2013-02-26       Impact factor: 32.419

5.  Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.

Authors:  Nathan Lo; Tesfaldet T Michael; Danyaal Moin; Vishal G Patel; Mohammed Alomar; Aristotelis Papayannis; Daisha Cipher; Shuaib M Abdullah; Subhash Banerjee; Emmanouil S Brilakis
Journal:  JACC Cardiovasc Interv       Date:  2013-12-11       Impact factor: 11.195

6.  Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions.

Authors:  M J Grundeken; M Smits; R E Harskamp; P Damman; P Woudstra; A J Hoorweg; J Baan; E K Arkenbout; J J Piek; M M Vis; J P S Henriques; K T Koch; J G Tijssen; R J de Winter; J J Wykrzykowska
Journal:  Neth Heart J       Date:  2012-11       Impact factor: 2.380

Review 7.  Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?

Authors:  Franz-Josef Neumann
Journal:  Herz       Date:  2022-08-12       Impact factor: 1.740

Review 8.  Universal MI definition update for cardiovascular disease.

Authors:  Harvey White; Kristian Thygesen; Joseph S Alpert; Allan Jaffe
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

9.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

10.  Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.

Authors:  Bernard R Chaitman; Karen P Alexander; Derek D Cyr; Jeffrey S Berger; Harmony R Reynolds; Sripal Bangalore; William E Boden; Renato D Lopes; Marcin Demkow; Gian Piero Perna; Robert K Riezebos; Edward O McFalls; Subhash Banerjee; Akshay Bagai; Gilbert Gosselin; Sean M O'Brien; Frank W Rockhold; David D Waters; Kristian A Thygesen; Gregg W Stone; Harvey D White; David J Maron; Judith S Hochman
Journal:  Circulation       Date:  2020-12-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.